Vitamins
-Water soluble
-Fat soluble
Vitamin A
-fat-soluble vitamin ingested in the diet in
two forms.
-as retinol itself from animal sources or
-as provitamin carotene from plant sources
2. INTRODUCTION
• Vitamins
-Water soluble
-Fat soluble
• Vitamin A
-fat-soluble vitamin ingested in the diet in
two forms.
-as retinol itself from animal sources or
-as provitamin carotene from plant sources
Hamis Mkindi 2
3. Vitamin A deficiency(XEROPTHALMIA)
• literally means (xeros= dry ; ophthalmos = eye)
dryness of the eye
• Most important cause of blindness in children in
the world.
• Important factor in the cause of stunting which is
more prevalent than malnutrition.
• Important cause of ocular morbidity among
patients with chronic liver disease and lipid
malabsorption, and is a major cause of blindness
in developing countries
Hamis Mkindi 3
6. Vitamin A
• main molecular structure contains a cyclic part
and a non-cyclic chain with 5 double bonds in
the all-trans position.
• A functional group is found at the end of the
non-cyclic part which can be an alcohol
(retinol), an aldehyde (reninaldehyde), a
palmitate (retinolpalmitate)
Hamis Mkindi 6
7. Physiology
• Vitamin A intestinal mucosal cells,
carotene is converted to retinol and, along with
the directly ingested retinol, is esterified to
palmitic acid.
• Retinyl palmitate Liver(stored).
• In requirement for vitamin A, retinyl palmitate is
hydrolyzed, and the reconstituted retinol travels
via the blood stream, attached to retinol-binding
protein (RBP), to the tissue where it is needed.
Lymphatic
system
Absorbed
from SI
Hamis Mkindi 7
8. Physiology cont
• Adequate body stores of zinc and protein are
necessary for the formation of RBP.
• Eye:vitamin A has a pivotal role in the
functioning of the retina and the conjunctiva.
• Retina contains two distinct photoreceptor
systems,the rods and the cones.
Hamis Mkindi 8
10. • Vitamin A is the backbone of the visual pigments
for the rods and the cones.
• Rod cells: the aldehyde form of vitamin A (retinal)
and the protein opsin combine to create
rhodopsin, which is the photosensitive pigment.
• When light hits the rod cells, the pigment
isomerizes, which leads to the nerve impulse and
results in the visual signal.
• The pigment is broken down to opsin and the
stereoisomer of retinal.
Hamis Mkindi 10
11. • Conjunctiva:vitamin A is necessary for the
maintenance of the specialized epithelial
surface.
• A lack of vitamin A leads to atrophic changes
in the normal mucosal surface, with loss of
goblet cells, and replacement of the normal
epithelium by an inappropriate keratinized
stratified squamous epithelium.
Hamis Mkindi 11
12. • Also,the substantia propria of the cornea
breaks down and liquefies (colliquative
necrosis), resulting in keratomalacia.
• Vitamin A deficiency affects the retina,
conjunctiva, and cornea, and the signs and
symptoms tend to occur in a reliable
sequence.
Hamis Mkindi 12
13. Risk factors
• Both an insufficient input and an increased need can
result in the deficiency.
• Infections of the gut, malabsorption, worm infestations
and particularly giardiasis decrease vitamin A
absorption,PEM.
• Recommended daily intakes
• Adult: 750 µg
• Pregnancy: 750 µg
• Breastfeeding: 1200 µg
• Children:
• < 1 yr: 300 µg
• 1-4 yr: 250 µg
• 4-6 yr: 300 µg
• 7-9 yr: 400 µg
• 10-12 yr: 575 µg
• 13-15 yr: 725 µg
Hamis Mkindi 13
14. The WHO classification of vitamin A
deficiency is as follows:
• XN Night blindness
• X1A Conjunctival xerosis
• XIB Bitot’s spot
• X2 Corneal xerosis
• X3A Corneal ulceration/keratomalacia
-involving one-third or less of the cornea
• X3B Corneal ulceration/keratomalacia
-involving one-half or more of the cornea
• XS Corneal scar
Hamis Mkindi 14
18. Diagnosis
• Clinical:Night blindness and xerosis are the
initial signs of vitamin A deficiency, followed
by formation of Bitot’s spot.
• Serum levels of vitamin A
• CIC.
Hamis Mkindi 18
19. Treatment
• Considered and emergency.
• Large and repeated doses are therefore given.
• Associated illnesses should always be Rx.
• Oral therapy: The oral regimen of vitamin A is 200,000 IU
on day of presentation, next day, and 2–4 weeks later.
• Children less than 1 year of age or less than 8 kg should
receive half the dose of the above dose. Repeat 200,000 IU
every 6 months up to 6 years of age to prevent recurrence.
Hamis Mkindi 19